U.S. Markets close in 5 hrs 31 mins

Takeda Pharmaceutical Company Limited (TKPYY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
26.94+0.01 (+0.04%)
As of 10:05AM EDT. Market open.
People also watch
ALPMYESALYDSNKYTKPHFSVNDY
Full screen
Previous Close26.93
Open26.93
Bid0.00 x 0
Ask0.00 x 0
Day's Range26.93 - 26.94
52 Week Range19.96 - 27.35
Volume198,543
Avg. Volume56,576
Market Cap41.66B
Beta0.41
PE Ratio (TTM)41.26
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.78 (2.90%)
Ex-Dividend Date2016-09-28
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist6 days ago

    How Celgene’s Pomalyst Is Positioned after 2Q17

    In 2Q17, Celgene’s (CELG) Pomalyst generated revenues of ~$391 million, which reflected ~23% growth on a year-over-year basis.

  • Capital Cube13 days ago

    ETFs with exposure to Takeda Pharmaceutical Co., Ltd. : August 4, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Takeda Pharmaceutical Co., Ltd. Here are 5 ETFs with the largest exposure to TKPYY-US. Comparing the performance and risk of Takeda Pharmaceutical Co., Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Seattle Genetics (SGEN) Q2 Loss Narrower than Expected
    Zacks19 days ago

    Seattle Genetics (SGEN) Q2 Loss Narrower than Expected

    Seattle Genetics (SGEN) incurred narrower-than-expected loss in Q2 and provided an encouraging guidance for Adcetris.